Aqueous extract of Inonotus bliquus (Fr.) Pilat Hymenochaetaceae) significantly inhibits the growth of Sarcoma 180 by inducing apoptosis

American Journal of Pharmacology and Toxicology

Volumn 2, Issue 1, 2007, Pages 10-17

  Chen, Caifa ^a   Zheng, Weifa ^a   Gao, Xiaowen ^a   Xiang, Xiaoyan ^a   Sun, Dongxu ^a   Wei, Jiangchun ^a   Chu, Chengcai ^b  

^a JIANGSU NORMAL UNIVERSITY   (China)

^b INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

Antitumor activity; Apoptosis; Aqueous extract; Inonotus obliquus

Indexed keywords

INONOTUS OBLIQUUS EXTRACT; PLACEBO; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DOSE COMPARISON; DRUG SELECTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INSTITUTE FOR CANCER RESEARCH MOUSE; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; SARCOMA 180; SCLEROTIUM (BASIDIOMYCOTA); SPLEEN LYMPHOCYTE; TUMOR REGRESSION;

FUNGI; HYMENOCHAETACEAE; INONOTUS; INONOTUS OBLIQUUS; MUS; SCLEROTIUM (ASCOMYCOTA);

EID: 34047184217     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2007.10.17     Document Type: Article

References (35)

1. Huang, L.N., 2002. The mysterious folk medicinal fungus-Inonotus obliquus. Edible Fungi Chin., 21: 7-8.
2. Burczyk, J., A. Gawron, M. Slotwinska, B. Smietana and K. Terminska, 1996. Antimitotic activity of aqueous extracts of Inonotus obliquus. Boll. Chim. Pharm., 135: 306-9.
3. Rzymowska, J., 1998. The effect of aqueous extracts from Inonotus obliquus on the mitotic index and enzyme activities. Boll. Chim. Pharm., 137: 13-5.
4. Park, Y.K., H.B. Lee, E.J. Jeon, H.S. Jung and M.H. Kang, 2004. Chaga mushroom extract inhibits oxidative DNA damage in human lymphocytes as assessed by comet assy. BioFactors, 21: 109-12.
5. Mizuno, T., C. Zhuang, K. Abe, H. Okamoto, T. Kiho, S. Ukai, S. Leclerc and L. Meijer, 1999. Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus. Intl. J. Med. Mush., 1: 301-16.
6. Li, Y.X., J.C. Cui, D.Z. Sun, Y.Z. Gao and Y. Cui, 2003. Effect of extractions from edible fungus Inonotus obliquus (Fr.) Pilat on anti proliferation and apoptosis inducement of MGC-803 cells of gastric cancer. J. Fun. Res., 1: 17-23.
7. Cui, Y., D.S. Kim and K.C. Park, 1997. Antioxidant effect of Inonotus obliquus. J. Ethnopharmcol., 96: 79-85.
8. Chouaib, S., C. Asselin-Paturel, F. Mai-Chouaib, A. Caignard and J.Y. Blay, 1997. The host-tumor immune conflict: From immunosuppression to resistance and destruction. Immunol. Today, 18: 493-7.
9. Pawelec, G., J. Zeuthen and R. Kiessling, 1997. Escape from host-antitumor immunity. Crit. Rev. Oncol., 8: 111-41.
10. Shu, S., G.E. Plautz, J.C. Krauss and A.E. Chang, 1997. Tumor immunology. J. Am. Med. Assoc., 278: 1972-81.
11. Chen, L., 1998. Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol. Today, 19: 27-30.
12. Seliger, B., 2005. Strategies of tumor immune evasion. BioDrugs, 19: 347-54.
13. Kymionis, G.D., C.E. Dimitrakakis, M.M. Konstadoulakis, I. Arzimanoglou, E. Leandros, G, Chalkiadais, A. Keramopoulos and S. Michala, 2001. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients? J. Surg. Res., 99: 161-8.
14. Pratesi, G., D. Polizzi, P. Perego, L. Dal Bo and F. Zunino, 2000. Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs. Biochem. Pharmacol., 60: 77-82.
15. Bhattacharyya, A., D. Mandal, L. Lahiry, G. Sa and T. Das, 2004. Black tea protects immunocytes from tumor-induced apoptosis by changing Bcl-2/ Bax ratio. Cancer Lett., 209: 147-54.
16. Page, M., N. Bejaoui, B. Cinq-Mars and P. Lemieux, 1988. Optimization of the terazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunopharmacol., 10: 785-93.
17. Tomai, M.A., L.M. Imbertson, T.L. Stanczak, L.T. Tygrett and T.J. Waldschmidt, 2000. The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes. Cellular Immunol., 203: 55-65.
18. 3H] thymedine incorporation with MTT- and MTS-based bioassys for human and murine IL-2 and IL-14 analysis Tetrazolium assays provide markedly enhanced sensitivity. J. Immunol. Methods, 187: 85-93.
19. + T cell proliferation in bovine leukemia virus infected animals with persistent lymphocytosis. J. Immunol. Methods, 199: 159-65.
20. Zheng, W.F., C.F. Chen and Q.P. Cheng, 2005. Antitumor activity of exopolysaccharide from Aphanothece halophytica. Chin Tradit Herbal Drugs, 36: 1026-30.
21. Krajewski, S., M. Krajewska, A. Shabaik, H.G. Wang, S. Irie, L. Fong and J.C. Reed, 1994. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res., 54: 5501-7.
22. Krajewski, S., C. Blomvqvist, K. Franssila, M. Krajewska, V.M. Wasenius, E. Niskanen, S. Nordling and J.C. Reed, 1995. Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastic breast adenocarcinoma. Cancer Res., 55: 4471-8.
23. Kim, H.M., C.H. Oh and C.K. Chung, 1999. Activation of inducible nitric oxide synthase by Taraxacum officinale in mouse peritoneal macrophages. Gen. Pharmacol., 32: 683-8.
24. Ghosh, M., U. Sadhu, S.D. Bhattacharya, B. Bhattacharya and U. Sanyal, 1999. Evaluation of toxicity of betatethymustine, A new anticancer compound in mice. Cancer Lett., 138: 107-14.
25. Shanker, A., S.M. Singh and A. Sodhi, 2000. Ascitic growth of a spontaneous transplantable T cell lymphoma induces thymic involution. 2. Induction of apoptosis in thymocytes. Tumor Bio., 21: 315-27.
26. Bhattacharyya, A., T. Choudhuri, S. Pal, S. Chattopadhyay, G.K. Datta, G. Sa and T. Das, 2003. Apoptogenic effects of black tea on Ehrlich's ascites carcinoma cell. Carcinogenesis, 24: 75-80.
27. Nagarkatti, N., 2000. Turmor-derived Fas ligand induces toxicity in lymphoid organs and play an important role in successful chemotherapy. Cancer Immunol. Immun., 49: 46-55.
28. Kaufmann, S.H. and W.C. Earnshaw, 2000. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res., 256: 42-9.
29. Johnstone, R.W., A.A. Ruefli and S.W. Lowe, 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell, 108: 153-64.
30. Brantley-Finley, C., C.S. Lyle, L. Du, M.E. Goodwin, T. Hall, D. Szwedo, G.P. Kaushal and T.C. Chambers, 2003. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin and etoposide. Biochem. Pharmacol., 66: 459-69.
31. Zheng, J.Y., G.S. Yang, W.Z. Wang, J. Li, L.Z. Li, W.X. Guan and W.L. Wang, 2005. Over expression of Bax induces apoptosis and enhances drug sensitivity of hepatocellular cancer-9204 cells. World J. Gastroenterol., 11: 3498-503.
32. Suffness, M., and J.M. Pezzuto, 1991. Methods in Plant Biochemistry. Academic Press, New York, Vol. V1, pp: 7.
33. Ishiki, N., H. Onishi and Y. Machida, 2004. Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates. Intl. J. Pharma., 279: 81-93.
34. Mocellin, S., C.R. Rossi, P. Pilati and D. Nitti, 2005. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor, 16: 35-53.
35. Leist, M. and M. Jaattela, 2001. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Bio., 2: 589-98.